Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08835_nanopub.RAHPn6g8H4xkXbg6Jz1W1A52puGsP9BvSq_xCGMfocUA8#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB08835 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08835 label "Spaglumic Acid [drugbank:DB08835]" assertion.
- drugbank:DB08835 seeAlso DB08835 assertion.
- drugbank:DB08835 seeAlso spaglumic-acid.html assertion.
- drugbank:DB08835 identifier "drugbank:DB08835" assertion.
- drugbank:DB08835 description "Spaglumic acid is the β-aspartyl isoform of N-Acetyl-l-aspartylglutamate (isospaglumic Acid is N-(N-Acetyl-l-α-aspartyl)-l-glutamic acid). In eye drops, spaglumic acid is either a magnesium or sodium salt of N-Acetyl-l-aspartylglutamate. Spaglumic acid is a mast cell stabilizer. Thus it is used in allergic conditions such as allergic conjunctivitis. Specifically spaglumic acid is approved in Portugal under the brand name Naabak and in Greece under the brand name Naaxia for use in patients with allergic conjunctivitis." assertion.
- drugbank:DB08835 title "Spaglumic Acid" assertion.
- drugbank:DB08835 bio2rdf_vocabulary:identifier "DB08835" assertion.
- drugbank:DB08835 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08835 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08835" assertion.
- drugbank:DB08835 bio2rdf_vocabulary:x-identifiers.org DB08835 assertion.
- drugbank:DB08835 drugbank_vocabulary:drugbank-id "DB08835" assertion.
- drugbank:DB08835 drugbank_vocabulary:x-cas cas:4910-46-7 assertion.
- drugbank:DB08835 drugbank_vocabulary:x-atc atc:R01AC05 assertion.
- drugbank:DB08835 drugbank_vocabulary:x-kegg kegg:D07374 assertion.
- drugbank:DB08835 drugbank_vocabulary:x-wikipedia wikipedia:N-Acetylaspartylglutamic_acid assertion.